nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—SLC22A5—Dactinomycin—sarcoma	0.551	1	CbGbCtD
Cefdinir—Erythema multiforme—Dactinomycin—sarcoma	0.00173	0.00389	CcSEcCtD
Cefdinir—Stomatitis—Mitoxantrone—sarcoma	0.00172	0.00389	CcSEcCtD
Cefdinir—Jaundice—Mitoxantrone—sarcoma	0.00172	0.00389	CcSEcCtD
Cefdinir—Conjunctivitis—Mitoxantrone—sarcoma	0.00172	0.00388	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Etoposide—sarcoma	0.00172	0.00388	CcSEcCtD
Cefdinir—Haematuria—Mitoxantrone—sarcoma	0.00169	0.0038	CcSEcCtD
Cefdinir—Agranulocytosis—Mitoxantrone—sarcoma	0.00165	0.00372	CcSEcCtD
Cefdinir—Haemoglobin—Mitoxantrone—sarcoma	0.0016	0.0036	CcSEcCtD
Cefdinir—Haemorrhage—Mitoxantrone—sarcoma	0.00159	0.00358	CcSEcCtD
Cefdinir—Dyskinesia—Epirubicin—sarcoma	0.00157	0.00354	CcSEcCtD
Cefdinir—Pancytopenia—Etoposide—sarcoma	0.00157	0.00353	CcSEcCtD
Cefdinir—Neutropenia—Etoposide—sarcoma	0.00154	0.00348	CcSEcCtD
Cefdinir—Pneumonia—Etoposide—sarcoma	0.00148	0.00334	CcSEcCtD
Cefdinir—Vaginal inflammation—Epirubicin—sarcoma	0.00147	0.00332	CcSEcCtD
Cefdinir—Agitation—Thiotepa—sarcoma	0.00147	0.00332	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00146	0.00329	CcSEcCtD
Cefdinir—Dyskinesia—Doxorubicin—sarcoma	0.00145	0.00327	CcSEcCtD
Cefdinir—Acute coronary syndrome—Etoposide—sarcoma	0.00145	0.00327	CcSEcCtD
Cefdinir—Renal failure—Etoposide—sarcoma	0.00145	0.00326	CcSEcCtD
Cefdinir—Myocardial infarction—Etoposide—sarcoma	0.00144	0.00325	CcSEcCtD
Cefdinir—Melaena—Epirubicin—sarcoma	0.00144	0.00325	CcSEcCtD
Cefdinir—Stomatitis—Etoposide—sarcoma	0.00143	0.00323	CcSEcCtD
Cefdinir—Jaundice—Etoposide—sarcoma	0.00143	0.00323	CcSEcCtD
Cefdinir—Leukopenia—Thiotepa—sarcoma	0.00143	0.00323	CcSEcCtD
Cefdinir—Leukopenia—Dactinomycin—sarcoma	0.00142	0.00321	CcSEcCtD
Cefdinir—Candida infection—Epirubicin—sarcoma	0.00141	0.00317	CcSEcCtD
Cefdinir—Vaginal infection—Epirubicin—sarcoma	0.00139	0.00314	CcSEcCtD
Cefdinir—Convulsion—Thiotepa—sarcoma	0.00139	0.00313	CcSEcCtD
Cefdinir—Aplastic anaemia—Epirubicin—sarcoma	0.00138	0.00312	CcSEcCtD
Cefdinir—Hypertension—Thiotepa—sarcoma	0.00138	0.00312	CcSEcCtD
Cefdinir—Agranulocytosis—Etoposide—sarcoma	0.00137	0.0031	CcSEcCtD
Cefdinir—Vaginal inflammation—Doxorubicin—sarcoma	0.00136	0.00308	CcSEcCtD
Cefdinir—Rash maculo-papular—Epirubicin—sarcoma	0.00134	0.00302	CcSEcCtD
Cefdinir—Melaena—Doxorubicin—sarcoma	0.00133	0.003	CcSEcCtD
Cefdinir—Agitation—Vincristine—sarcoma	0.0013	0.00294	CcSEcCtD
Cefdinir—Candida infection—Doxorubicin—sarcoma	0.0013	0.00294	CcSEcCtD
Cefdinir—Vaginal infection—Doxorubicin—sarcoma	0.00129	0.0029	CcSEcCtD
Cefdinir—Aplastic anaemia—Doxorubicin—sarcoma	0.00128	0.00289	CcSEcCtD
Cefdinir—Thrombocytopenia—Thiotepa—sarcoma	0.00128	0.00288	CcSEcCtD
Cefdinir—Leukopenia—Vincristine—sarcoma	0.00127	0.00286	CcSEcCtD
Cefdinir—Thrombocytopenia—Dactinomycin—sarcoma	0.00127	0.00286	CcSEcCtD
Cefdinir—Erythema multiforme—Etoposide—sarcoma	0.00125	0.00282	CcSEcCtD
Cefdinir—Anorexia—Thiotepa—sarcoma	0.00125	0.00281	CcSEcCtD
Cefdinir—Rash maculo-papular—Doxorubicin—sarcoma	0.00124	0.0028	CcSEcCtD
Cefdinir—Leukopenia—Mitoxantrone—sarcoma	0.00124	0.00279	CcSEcCtD
Cefdinir—Anorexia—Dactinomycin—sarcoma	0.00124	0.00279	CcSEcCtD
Cefdinir—Convulsion—Vincristine—sarcoma	0.00123	0.00277	CcSEcCtD
Cefdinir—Hypertension—Vincristine—sarcoma	0.00123	0.00276	CcSEcCtD
Cefdinir—Hepatic function abnormal—Epirubicin—sarcoma	0.00122	0.00276	CcSEcCtD
Cefdinir—Convulsion—Mitoxantrone—sarcoma	0.0012	0.0027	CcSEcCtD
Cefdinir—Hypertension—Mitoxantrone—sarcoma	0.00119	0.00269	CcSEcCtD
Cefdinir—Hepatic failure—Epirubicin—sarcoma	0.00119	0.00269	CcSEcCtD
Cefdinir—Chest pain—Mitoxantrone—sarcoma	0.00118	0.00265	CcSEcCtD
Cefdinir—Somnolence—Thiotepa—sarcoma	0.00116	0.00262	CcSEcCtD
Cefdinir—Renal failure acute—Epirubicin—sarcoma	0.00116	0.00261	CcSEcCtD
Cefdinir—Anaphylactic shock—Vincristine—sarcoma	0.00116	0.00261	CcSEcCtD
Cefdinir—Dyspepsia—Thiotepa—sarcoma	0.00115	0.00259	CcSEcCtD
Cefdinir—Decreased appetite—Thiotepa—sarcoma	0.00114	0.00256	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Epirubicin—sarcoma	0.00113	0.00256	CcSEcCtD
Cefdinir—Thrombocytopenia—Vincristine—sarcoma	0.00113	0.00256	CcSEcCtD
Cefdinir—Hepatic function abnormal—Doxorubicin—sarcoma	0.00113	0.00255	CcSEcCtD
Cefdinir—Anaphylactic shock—Mitoxantrone—sarcoma	0.00113	0.00254	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Thiotepa—sarcoma	0.00113	0.00254	CcSEcCtD
Cefdinir—Decreased appetite—Dactinomycin—sarcoma	0.00113	0.00254	CcSEcCtD
Cefdinir—Renal impairment—Epirubicin—sarcoma	0.00112	0.00254	CcSEcCtD
Cefdinir—Constipation—Thiotepa—sarcoma	0.00112	0.00252	CcSEcCtD
Cefdinir—Purpura—Epirubicin—sarcoma	0.00111	0.0025	CcSEcCtD
Cefdinir—Shock—Mitoxantrone—sarcoma	0.00111	0.0025	CcSEcCtD
Cefdinir—Thrombocytopenia—Mitoxantrone—sarcoma	0.0011	0.00249	CcSEcCtD
Cefdinir—Anorexia—Vincristine—sarcoma	0.0011	0.00249	CcSEcCtD
Cefdinir—Hepatic failure—Doxorubicin—sarcoma	0.0011	0.00248	CcSEcCtD
Cefdinir—Cardiac failure—Epirubicin—sarcoma	0.0011	0.00247	CcSEcCtD
Cefdinir—Anorexia—Mitoxantrone—sarcoma	0.00108	0.00242	CcSEcCtD
Cefdinir—Renal failure acute—Doxorubicin—sarcoma	0.00107	0.00242	CcSEcCtD
Cefdinir—Gastrointestinal pain—Thiotepa—sarcoma	0.00107	0.00241	CcSEcCtD
Cefdinir—Gastrointestinal pain—Dactinomycin—sarcoma	0.00106	0.00239	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Doxorubicin—sarcoma	0.00105	0.00237	CcSEcCtD
Cefdinir—Insomnia—Vincristine—sarcoma	0.00105	0.00236	CcSEcCtD
Cefdinir—Renal impairment—Doxorubicin—sarcoma	0.00104	0.00235	CcSEcCtD
Cefdinir—Abdominal pain—Thiotepa—sarcoma	0.00103	0.00233	CcSEcCtD
Cefdinir—Body temperature increased—Thiotepa—sarcoma	0.00103	0.00233	CcSEcCtD
Cefdinir—Leukopenia—Etoposide—sarcoma	0.00103	0.00232	CcSEcCtD
Cefdinir—Purpura—Doxorubicin—sarcoma	0.00103	0.00232	CcSEcCtD
Cefdinir—Body temperature increased—Dactinomycin—sarcoma	0.00103	0.00231	CcSEcCtD
Cefdinir—Abdominal pain—Dactinomycin—sarcoma	0.00103	0.00231	CcSEcCtD
Cefdinir—Cardiac failure—Doxorubicin—sarcoma	0.00101	0.00229	CcSEcCtD
Cefdinir—Loss of consciousness—Etoposide—sarcoma	0.00101	0.00228	CcSEcCtD
Cefdinir—Decreased appetite—Vincristine—sarcoma	0.00101	0.00227	CcSEcCtD
Cefdinir—Somnolence—Mitoxantrone—sarcoma	0.001	0.00226	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Vincristine—sarcoma	0.001	0.00225	CcSEcCtD
Cefdinir—Convulsion—Etoposide—sarcoma	0.000996	0.00225	CcSEcCtD
Cefdinir—Dyspepsia—Mitoxantrone—sarcoma	0.000993	0.00224	CcSEcCtD
Cefdinir—Hypertension—Etoposide—sarcoma	0.000993	0.00224	CcSEcCtD
Cefdinir—Constipation—Vincristine—sarcoma	0.000991	0.00223	CcSEcCtD
Cefdinir—Decreased appetite—Mitoxantrone—sarcoma	0.000981	0.00221	CcSEcCtD
Cefdinir—Chest pain—Etoposide—sarcoma	0.000979	0.00221	CcSEcCtD
Cefdinir—Constipation—Mitoxantrone—sarcoma	0.000965	0.00218	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000964	0.00217	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000964	0.00217	CcSEcCtD
Cefdinir—Hypersensitivity—Thiotepa—sarcoma	0.000963	0.00217	CcSEcCtD
Cefdinir—Hypersensitivity—Dactinomycin—sarcoma	0.000955	0.00215	CcSEcCtD
Cefdinir—Gastrointestinal pain—Vincristine—sarcoma	0.000947	0.00214	CcSEcCtD
Cefdinir—Anaphylactic shock—Etoposide—sarcoma	0.000939	0.00212	CcSEcCtD
Cefdinir—Asthenia—Thiotepa—sarcoma	0.000937	0.00211	CcSEcCtD
Cefdinir—Asthenia—Dactinomycin—sarcoma	0.00093	0.0021	CcSEcCtD
Cefdinir—Asthma—Epirubicin—sarcoma	0.000925	0.00209	CcSEcCtD
Cefdinir—Pruritus—Thiotepa—sarcoma	0.000924	0.00208	CcSEcCtD
Cefdinir—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000923	0.00208	CcSEcCtD
Cefdinir—Thrombocytopenia—Etoposide—sarcoma	0.000919	0.00207	CcSEcCtD
Cefdinir—Body temperature increased—Vincristine—sarcoma	0.000916	0.00206	CcSEcCtD
Cefdinir—Abdominal pain—Vincristine—sarcoma	0.000916	0.00206	CcSEcCtD
Cefdinir—Anorexia—Etoposide—sarcoma	0.000895	0.00202	CcSEcCtD
Cefdinir—Diarrhoea—Thiotepa—sarcoma	0.000894	0.00202	CcSEcCtD
Cefdinir—Abdominal pain—Mitoxantrone—sarcoma	0.000892	0.00201	CcSEcCtD
Cefdinir—Body temperature increased—Mitoxantrone—sarcoma	0.000892	0.00201	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000892	0.00201	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000892	0.00201	CcSEcCtD
Cefdinir—Diarrhoea—Dactinomycin—sarcoma	0.000887	0.002	CcSEcCtD
Cefdinir—Pancytopenia—Epirubicin—sarcoma	0.000879	0.00198	CcSEcCtD
Cefdinir—Neutropenia—Epirubicin—sarcoma	0.000865	0.00195	CcSEcCtD
Cefdinir—Dizziness—Thiotepa—sarcoma	0.000864	0.00195	CcSEcCtD
Cefdinir—Asthma—Doxorubicin—sarcoma	0.000856	0.00193	CcSEcCtD
Cefdinir—Hypersensitivity—Vincristine—sarcoma	0.000854	0.00192	CcSEcCtD
Cefdinir—Somnolence—Etoposide—sarcoma	0.000834	0.00188	CcSEcCtD
Cefdinir—Hypersensitivity—Mitoxantrone—sarcoma	0.000831	0.00187	CcSEcCtD
Cefdinir—Asthenia—Vincristine—sarcoma	0.000831	0.00187	CcSEcCtD
Cefdinir—Vomiting—Thiotepa—sarcoma	0.000831	0.00187	CcSEcCtD
Cefdinir—Pneumonia—Epirubicin—sarcoma	0.00083	0.00187	CcSEcCtD
Cefdinir—Vomiting—Dactinomycin—sarcoma	0.000825	0.00186	CcSEcCtD
Cefdinir—Rash—Thiotepa—sarcoma	0.000824	0.00186	CcSEcCtD
Cefdinir—Dermatitis—Thiotepa—sarcoma	0.000823	0.00186	CcSEcCtD
Cefdinir—Headache—Thiotepa—sarcoma	0.000819	0.00185	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000818	0.00184	CcSEcCtD
Cefdinir—Rash—Dactinomycin—sarcoma	0.000818	0.00184	CcSEcCtD
Cefdinir—Decreased appetite—Etoposide—sarcoma	0.000816	0.00184	CcSEcCtD
Cefdinir—Pancytopenia—Doxorubicin—sarcoma	0.000813	0.00183	CcSEcCtD
Cefdinir—Renal failure—Epirubicin—sarcoma	0.000811	0.00183	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Etoposide—sarcoma	0.00081	0.00183	CcSEcCtD
Cefdinir—Asthenia—Mitoxantrone—sarcoma	0.00081	0.00183	CcSEcCtD
Cefdinir—Stomatitis—Epirubicin—sarcoma	0.000804	0.00181	CcSEcCtD
Cefdinir—Jaundice—Epirubicin—sarcoma	0.000804	0.00181	CcSEcCtD
Cefdinir—Constipation—Etoposide—sarcoma	0.000803	0.00181	CcSEcCtD
Cefdinir—Conjunctivitis—Epirubicin—sarcoma	0.000802	0.00181	CcSEcCtD
Cefdinir—Neutropenia—Doxorubicin—sarcoma	0.0008	0.0018	CcSEcCtD
Cefdinir—Diarrhoea—Vincristine—sarcoma	0.000793	0.00179	CcSEcCtD
Cefdinir—Haematuria—Epirubicin—sarcoma	0.000787	0.00177	CcSEcCtD
Cefdinir—Nausea—Thiotepa—sarcoma	0.000776	0.00175	CcSEcCtD
Cefdinir—Diarrhoea—Mitoxantrone—sarcoma	0.000772	0.00174	CcSEcCtD
Cefdinir—Nausea—Dactinomycin—sarcoma	0.00077	0.00174	CcSEcCtD
Cefdinir—Agranulocytosis—Epirubicin—sarcoma	0.00077	0.00174	CcSEcCtD
Cefdinir—Pneumonia—Doxorubicin—sarcoma	0.000768	0.00173	CcSEcCtD
Cefdinir—Gastrointestinal pain—Etoposide—sarcoma	0.000767	0.00173	CcSEcCtD
Cefdinir—Dizziness—Vincristine—sarcoma	0.000766	0.00173	CcSEcCtD
Cefdinir—MPO—endothelium—sarcoma	0.000761	0.132	CbGeAlD
Cefdinir—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000757	0.00171	CcSEcCtD
Cefdinir—Renal failure—Doxorubicin—sarcoma	0.00075	0.00169	CcSEcCtD
Cefdinir—Haemoglobin—Epirubicin—sarcoma	0.000744	0.00168	CcSEcCtD
Cefdinir—Jaundice—Doxorubicin—sarcoma	0.000744	0.00168	CcSEcCtD
Cefdinir—Stomatitis—Doxorubicin—sarcoma	0.000744	0.00168	CcSEcCtD
Cefdinir—Abdominal pain—Etoposide—sarcoma	0.000742	0.00167	CcSEcCtD
Cefdinir—Body temperature increased—Etoposide—sarcoma	0.000742	0.00167	CcSEcCtD
Cefdinir—Conjunctivitis—Doxorubicin—sarcoma	0.000742	0.00167	CcSEcCtD
Cefdinir—Haemorrhage—Epirubicin—sarcoma	0.000741	0.00167	CcSEcCtD
Cefdinir—Vomiting—Vincristine—sarcoma	0.000737	0.00166	CcSEcCtD
Cefdinir—Rash—Vincristine—sarcoma	0.000731	0.00165	CcSEcCtD
Cefdinir—Dermatitis—Vincristine—sarcoma	0.00073	0.00165	CcSEcCtD
Cefdinir—Haematuria—Doxorubicin—sarcoma	0.000728	0.00164	CcSEcCtD
Cefdinir—Headache—Vincristine—sarcoma	0.000726	0.00164	CcSEcCtD
Cefdinir—Vomiting—Mitoxantrone—sarcoma	0.000717	0.00162	CcSEcCtD
Cefdinir—Agranulocytosis—Doxorubicin—sarcoma	0.000712	0.00161	CcSEcCtD
Cefdinir—Rash—Mitoxantrone—sarcoma	0.000711	0.0016	CcSEcCtD
Cefdinir—Dermatitis—Mitoxantrone—sarcoma	0.000711	0.0016	CcSEcCtD
Cefdinir—Headache—Mitoxantrone—sarcoma	0.000707	0.00159	CcSEcCtD
Cefdinir—Erythema multiforme—Epirubicin—sarcoma	0.0007	0.00158	CcSEcCtD
Cefdinir—Hypersensitivity—Etoposide—sarcoma	0.000691	0.00156	CcSEcCtD
Cefdinir—Haemoglobin—Doxorubicin—sarcoma	0.000689	0.00155	CcSEcCtD
Cefdinir—Nausea—Vincristine—sarcoma	0.000688	0.00155	CcSEcCtD
Cefdinir—Haemorrhage—Doxorubicin—sarcoma	0.000685	0.00154	CcSEcCtD
Cefdinir—Asthenia—Etoposide—sarcoma	0.000673	0.00152	CcSEcCtD
Cefdinir—Nausea—Mitoxantrone—sarcoma	0.00067	0.00151	CcSEcCtD
Cefdinir—Pruritus—Etoposide—sarcoma	0.000664	0.0015	CcSEcCtD
Cefdinir—Erythema multiforme—Doxorubicin—sarcoma	0.000648	0.00146	CcSEcCtD
Cefdinir—Diarrhoea—Etoposide—sarcoma	0.000642	0.00145	CcSEcCtD
Cefdinir—Flatulence—Epirubicin—sarcoma	0.000635	0.00143	CcSEcCtD
Cefdinir—Dizziness—Etoposide—sarcoma	0.000621	0.0014	CcSEcCtD
Cefdinir—Vomiting—Etoposide—sarcoma	0.000597	0.00135	CcSEcCtD
Cefdinir—Agitation—Epirubicin—sarcoma	0.000592	0.00134	CcSEcCtD
Cefdinir—Rash—Etoposide—sarcoma	0.000592	0.00133	CcSEcCtD
Cefdinir—Dermatitis—Etoposide—sarcoma	0.000591	0.00133	CcSEcCtD
Cefdinir—Headache—Etoposide—sarcoma	0.000588	0.00133	CcSEcCtD
Cefdinir—Flatulence—Doxorubicin—sarcoma	0.000588	0.00133	CcSEcCtD
Cefdinir—Leukopenia—Epirubicin—sarcoma	0.000577	0.0013	CcSEcCtD
Cefdinir—Loss of consciousness—Epirubicin—sarcoma	0.000567	0.00128	CcSEcCtD
Cefdinir—Convulsion—Epirubicin—sarcoma	0.000559	0.00126	CcSEcCtD
Cefdinir—Nausea—Etoposide—sarcoma	0.000557	0.00126	CcSEcCtD
Cefdinir—Hypertension—Epirubicin—sarcoma	0.000557	0.00125	CcSEcCtD
Cefdinir—Chest pain—Epirubicin—sarcoma	0.000549	0.00124	CcSEcCtD
Cefdinir—Agitation—Doxorubicin—sarcoma	0.000548	0.00124	CcSEcCtD
Cefdinir—Dry mouth—Epirubicin—sarcoma	0.000537	0.00121	CcSEcCtD
Cefdinir—Leukopenia—Doxorubicin—sarcoma	0.000534	0.0012	CcSEcCtD
Cefdinir—Anaphylactic shock—Epirubicin—sarcoma	0.000526	0.00119	CcSEcCtD
Cefdinir—Loss of consciousness—Doxorubicin—sarcoma	0.000524	0.00118	CcSEcCtD
Cefdinir—Shock—Epirubicin—sarcoma	0.000518	0.00117	CcSEcCtD
Cefdinir—Convulsion—Doxorubicin—sarcoma	0.000517	0.00117	CcSEcCtD
Cefdinir—Thrombocytopenia—Epirubicin—sarcoma	0.000515	0.00116	CcSEcCtD
Cefdinir—Hypertension—Doxorubicin—sarcoma	0.000515	0.00116	CcSEcCtD
Cefdinir—Chest pain—Doxorubicin—sarcoma	0.000508	0.00114	CcSEcCtD
Cefdinir—Anorexia—Epirubicin—sarcoma	0.000501	0.00113	CcSEcCtD
Cefdinir—Dry mouth—Doxorubicin—sarcoma	0.000497	0.00112	CcSEcCtD
Cefdinir—Anaphylactic shock—Doxorubicin—sarcoma	0.000487	0.0011	CcSEcCtD
Cefdinir—Shock—Doxorubicin—sarcoma	0.000479	0.00108	CcSEcCtD
Cefdinir—Thrombocytopenia—Doxorubicin—sarcoma	0.000477	0.00107	CcSEcCtD
Cefdinir—Insomnia—Epirubicin—sarcoma	0.000476	0.00107	CcSEcCtD
Cefdinir—Somnolence—Epirubicin—sarcoma	0.000468	0.00105	CcSEcCtD
Cefdinir—Anorexia—Doxorubicin—sarcoma	0.000464	0.00105	CcSEcCtD
Cefdinir—Dyspepsia—Epirubicin—sarcoma	0.000463	0.00104	CcSEcCtD
Cefdinir—Decreased appetite—Epirubicin—sarcoma	0.000457	0.00103	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Epirubicin—sarcoma	0.000454	0.00102	CcSEcCtD
Cefdinir—Constipation—Epirubicin—sarcoma	0.00045	0.00101	CcSEcCtD
Cefdinir—Insomnia—Doxorubicin—sarcoma	0.00044	0.000993	CcSEcCtD
Cefdinir—Somnolence—Doxorubicin—sarcoma	0.000433	0.000976	CcSEcCtD
Cefdinir—Gastrointestinal pain—Epirubicin—sarcoma	0.00043	0.00097	CcSEcCtD
Cefdinir—Dyspepsia—Doxorubicin—sarcoma	0.000428	0.000966	CcSEcCtD
Cefdinir—SLC15A2—mammary gland—sarcoma	0.000426	0.0741	CbGeAlD
Cefdinir—Decreased appetite—Doxorubicin—sarcoma	0.000423	0.000954	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00042	0.000947	CcSEcCtD
Cefdinir—Constipation—Doxorubicin—sarcoma	0.000416	0.000938	CcSEcCtD
Cefdinir—Body temperature increased—Epirubicin—sarcoma	0.000416	0.000938	CcSEcCtD
Cefdinir—Abdominal pain—Epirubicin—sarcoma	0.000416	0.000938	CcSEcCtD
Cefdinir—Gastrointestinal pain—Doxorubicin—sarcoma	0.000398	0.000897	CcSEcCtD
Cefdinir—Hypersensitivity—Epirubicin—sarcoma	0.000388	0.000874	CcSEcCtD
Cefdinir—Abdominal pain—Doxorubicin—sarcoma	0.000385	0.000868	CcSEcCtD
Cefdinir—Body temperature increased—Doxorubicin—sarcoma	0.000385	0.000868	CcSEcCtD
Cefdinir—Asthenia—Epirubicin—sarcoma	0.000377	0.000851	CcSEcCtD
Cefdinir—MPO—hematopoietic system—sarcoma	0.000374	0.065	CbGeAlD
Cefdinir—Pruritus—Epirubicin—sarcoma	0.000372	0.000839	CcSEcCtD
Cefdinir—SLC22A5—mammary gland—sarcoma	0.000371	0.0645	CbGeAlD
Cefdinir—Diarrhoea—Epirubicin—sarcoma	0.00036	0.000812	CcSEcCtD
Cefdinir—MPO—connective tissue—sarcoma	0.00036	0.0626	CbGeAlD
Cefdinir—Hypersensitivity—Doxorubicin—sarcoma	0.000359	0.000809	CcSEcCtD
Cefdinir—Asthenia—Doxorubicin—sarcoma	0.000349	0.000787	CcSEcCtD
Cefdinir—Dizziness—Epirubicin—sarcoma	0.000348	0.000784	CcSEcCtD
Cefdinir—Pruritus—Doxorubicin—sarcoma	0.000344	0.000776	CcSEcCtD
Cefdinir—Vomiting—Epirubicin—sarcoma	0.000335	0.000754	CcSEcCtD
Cefdinir—Diarrhoea—Doxorubicin—sarcoma	0.000333	0.000751	CcSEcCtD
Cefdinir—Rash—Epirubicin—sarcoma	0.000332	0.000748	CcSEcCtD
Cefdinir—Dermatitis—Epirubicin—sarcoma	0.000331	0.000747	CcSEcCtD
Cefdinir—Headache—Epirubicin—sarcoma	0.00033	0.000743	CcSEcCtD
Cefdinir—MPO—skin of body—sarcoma	0.000325	0.0565	CbGeAlD
Cefdinir—Dizziness—Doxorubicin—sarcoma	0.000322	0.000726	CcSEcCtD
Cefdinir—Nausea—Epirubicin—sarcoma	0.000312	0.000704	CcSEcCtD
Cefdinir—Vomiting—Doxorubicin—sarcoma	0.00031	0.000698	CcSEcCtD
Cefdinir—Rash—Doxorubicin—sarcoma	0.000307	0.000692	CcSEcCtD
Cefdinir—Dermatitis—Doxorubicin—sarcoma	0.000307	0.000691	CcSEcCtD
Cefdinir—Headache—Doxorubicin—sarcoma	0.000305	0.000687	CcSEcCtD
Cefdinir—Nausea—Doxorubicin—sarcoma	0.000289	0.000652	CcSEcCtD
Cefdinir—SLC15A2—seminal vesicle—sarcoma	0.000273	0.0475	CbGeAlD
Cefdinir—MPO—lymphoid tissue—sarcoma	0.000263	0.0458	CbGeAlD
Cefdinir—SLC22A5—myometrium—sarcoma	0.000263	0.0458	CbGeAlD
Cefdinir—MPO—bone marrow—sarcoma	0.00024	0.0417	CbGeAlD
Cefdinir—SLC22A5—seminal vesicle—sarcoma	0.000238	0.0413	CbGeAlD
Cefdinir—SLC15A1—liver—sarcoma	0.000215	0.0374	CbGeAlD
Cefdinir—MPO—testis—sarcoma	0.000205	0.0356	CbGeAlD
Cefdinir—SLC22A5—skin of body—sarcoma	0.000196	0.0342	CbGeAlD
Cefdinir—MPO—liver—sarcoma	0.000194	0.0337	CbGeAlD
Cefdinir—SLC22A5—cardiac atrium—sarcoma	0.000172	0.0298	CbGeAlD
Cefdinir—SLC22A5—tendon—sarcoma	0.000149	0.026	CbGeAlD
Cefdinir—MPO—lymph node—sarcoma	0.000148	0.0258	CbGeAlD
Cefdinir—SLC15A2—testis—sarcoma	0.000142	0.0248	CbGeAlD
Cefdinir—SLC22A5—testis—sarcoma	0.000124	0.0215	CbGeAlD
Cefdinir—SLC22A5—liver—sarcoma	0.000117	0.0204	CbGeAlD
Cefdinir—SLC15A2—lymph node—sarcoma	0.000103	0.0179	CbGeAlD
Cefdinir—SLC22A5—lymph node—sarcoma	8.97e-05	0.0156	CbGeAlD
